| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 10,360 | $363,586 | $35.10 | 07 Jan 2026 | Direct |
| NewAmsterdam Pharma Co N.V. | Director | Option (right to buy) | 15,300 | 07 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | 07 Jan 2026 | 2 | $0 | 4 | Director | 09 Jan 2026, 19:34 |
| NAMS | NewAmsterdam Pharma Co N.V. | 06 Jan 2025 | 2 | $0 | 4 | Director | 08 Jan 2025, 17:58 |
| NAMS | NewAmsterdam Pharma Co N.V. | 01 Jan 2024 | 1 | $0 | 4 | Director | 03 Jan 2024, 17:19 |
| NAMS | NewAmsterdam Pharma Co N.V. | 29 Dec 2023 | 0 | $0 | 3 | Director | 29 Dec 2023, 16:30 |